Issue : Clinical Pharmacist, July 2018, Vol 10, No 7
Sort by: Newest first Oldest first A-Z Z-A
-
Diagnosis and management of type 1 diabetes mellitus
An overview of management options for type 1 diabetes, the types of insulin, insulin regimens and strengths available for its day-to-day management as well as how to adjust doses and the role of carbohydrate counting and blood glucose monitoring.
-
Risk factors for mortality, hospitalisation and imprisonment in substance misuse patients Subscription
Pharmacists should be aware of the mortality rates and adverse outcomes, including hospitalisation and imprisonment, that are rife in illicit drug users and patients on opioid substitution therapy, in order to optimise patient safety and reduce adverse outcomes.
-
How genetic testing can help women with breast cancer avoid chemotherapy Subscription
By using Oncotype DX test technology, researchers behind the TAILORx trial have proven that invasive and often harmful chemotherapy needn’t be the only option for women with breast cancer.
-
Certain antipsychotics linked with increased risk of gestational diabetes Subscription
Women who continue taking olanzapine or quetiapine during pregnancy are more likely to develop gestational diabetes than those who discontinue atypical antipsychotic medication.
-
Strong evidence that HPV vaccination protects against cervical pre-cancer, review finds Subscription
There is strong evidence that vaccination against human papillomavirus (HPV) between the ages of 15 and 26 years protects against cervical pre-cancer in young women, concluded the authors of a recent Cochrane Review (9 May 2018).
-
New prescribing approach could reduce intravenous opioid exposure Subscription
A new standard of inpatient opioid prescribing preferring oral and subcutaneous administration may be associated with significant reductions in intravenous opioid exposure, results from a US study show.
-
Type 2 diabetes drug aids weight loss, study finds Subscription
Patients given GLP-1 receptor agonists to treat obesity lost weight compared with those treated with placebo.
-
Aspirin lowers risk of death in people with concomitant heart failure and diabetes Subscription
Aspirin reduces the risk of all-cause death or hospitalisation for heart failure in patients with concomitant type 2 diabetes and heart failure but increases the risk of non-fatal heart attack or stroke.
-
MDMA could enhance psychotherapy outcomes in people with PTSD Subscription
Research has shown ‘marked improvements’ in PTSD symptoms after MDMA use during psychotherapy.
-
Proton pump inhibitors linked to pneumonia risk beyond first year of use Subscription
Research into long-term proton pump inhibitor use among older adults has led to cautions over pneumonia risk.
Show 10 per page20 per page
